Form 4: Vertex Director Carney Reports Share Gift

Vertex Pharmaceuticals Director Lloyd Carney reported gifting 800 shares of common stock on November 19, 2025, reducing his direct beneficial ownership to 6,315 shares.

Summary

• Lloyd Carney, a Director at Vertex Pharmaceuticals Inc. (VRTX), reported a transaction involving common stock.
• On November 19, 2025, Carney disposed of 800 shares of common stock through a gift (transaction code 'G').
• The shares were disposed of at a price of $0, consistent with a gift.
• Following this transaction, Carney's direct beneficial ownership of Vertex Pharmaceuticals common stock stands at 6,315 shares.

Sentiment

Score: 5

Explanation: The filing reports a gift of shares by an insider, which is a neutral event from a market sentiment perspective. It is not a sale for cash that might indicate a lack of confidence, nor an acquisition that might signal strong conviction.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This filing reports a routine insider transaction by a director and does not provide information relevant to broader industry trends or competitive analysis.

Stakeholder Impact

• Shareholders: Minimal impact due to the small number of shares involved relative to the company's total outstanding shares and market capitalization. It represents a minor reduction in a director's direct holdings.

Key Dates

Keywords

Vertex Pharmaceuticals, VRTX, Lloyd Carney, Director, Insider Transaction, Form 4, Share Gift, Beneficial Ownership